Organigram Global (OGI) Free Cash Flow Growth (1y) (2019 - 2026)
Organigram Global (OGI) Free Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 44.93% |
| 10 | Organigram Global | 121.15 Mn | 154.23 Mn | 28.97 Mn | -112.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.30% |
| Dec 31, 2025 | -445.54% |
| May 31, 2021 | -161.12% |
| Feb 28, 2021 | -107,053,175.61% |
| Nov 30, 2020 | 834,416.81% |
| Aug 31, 2020 | 91.35% |
| May 31, 2020 | 3.42% |
| Feb 29, 2020 | 99.79% |
| Nov 25, 2019 | -30.53% |
| Aug 31, 2019 | -2,169.47% |